Please login to the form below

Not currently logged in
Email:
Password:

UK NHS must change says health chief

The PM Society's annual lecture hears that the UK's National Health Service is not sustainable in its current state

Pharmaceutical companies, the government, primary care trusts (PCTs) and GP consortia need to pull together to tackle the "tsunami" of long-term conditions that the UK health service is facing, the PM Society annual lecture heard.

Sir John Oldham, the Department of Health's national clinical lead for quality and productivity, told guests: "If we continue to manage people with long-term conditions as we do now the NHS is not sustainable. It's not about politics, it's about mathematics.

"We have to make a change. There are ways to treat people with multiple conditions to reduce hospital stays. The pharma industry can help by transferring knowledge to patients so they can co-manage their conditions. We need to shift from a bio-medical model to a social model," he added.

Meanwhile Leslie Galloway, chairman of the Ethical Medicines Industry Group, discussed value based pricing. "Many see it as a threat, but it is not designed to increase prices. We need constant pricing across the UK," he told the guests.

19th May 2011

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics